Leaflet VIRAFERONPEG 80mcg powder+solution for injection
Indicated for: viral infections; multiple sclerosis; cancer
Route of administration: injectable
Substance: peginterferon alfa 2B (antineoplastic agent)
ATC: L03AB10 (Antineoplastic and immunomodulating agents | Immunostimulants | Interferons)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Peginterferon alfa-2b is a medication used for the treatment of chronic hepatitis B and C, as well as certain types of cancer, such as malignant melanoma. It is a pegylated form of interferon that stimulates the immune system to fight viral infections and cancer cells.
The medication is administered as a subcutaneous injection, as directed by your doctor. It is important to follow the administration schedule and monitor liver function and other blood tests during treatment.
Side effects may include fatigue, flu-like symptoms, depression, nausea, or weight loss. In rare cases, severe reactions such as liver function impairment or autoimmune disorders may occur.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of peginterferon alfa-2b.
General data about VIRAFERONPEG 80mcg
- Substance: peginterferon alfa 2B
- Date of last drug list: 01-07-2013
- Commercial code: W52110004
- Concentration: 80mcg
- Pharmaceutical form: powder+solution for injection
- Quantity: 4
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for peginterferon alfa 2B
Concentrations available for peginterferon alfa 2B
- 100mcg
- 100mcg/0.5ml
- 120mcg
- 120mcg/0.5ml
- 150mcg
- 150mcg/0.5ml
- 50mcg
- 50mcg/0.5ml
- 80mcg
- 80mcg/0.5ml